Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
ScienceScopeIn recent years, Germany's strong data- and employee-protection laws have impeded several panels investigating misconduct allegations. For example, a committee investigating a clinical study in Göttingen had to get permission from all the patients involved before it could access the study's raw data (Science, 22 November 2002, p. 1531). An expert panel could advise investigators in such cases, says a DFG spokesperson. The moves drew praise from Peter Hans Hofschneider of the Max Planck Institute for Biochemistry in Martinsried, who has helped several whistleblowers make their charges public. DFG is "finally giving serious attention to the problem," he says.
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)